1-14 of 14
Keywords: Antiandrogens
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Further Areas
European Urology (1993) 24 (Suppl. 2): 122–124.
Published Online: 11 August 2017
...F.M.J. Debruyne 11 8 2017 Prostate-specific antigen Laparoscopic lymphadenectomy Neoadjuvant treatment Antiandrogens Total androgen blockade 1993 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other...
Journal Articles
Subject Area:
Further Areas
European Urology (1990) 18 (Suppl. 3): 30–33.
Published Online: 11 August 2017
...E.D. Crawford The effectiveness of leuprolide (an LHRH analog), alone or in combination with flutamide (a nonsteroidal antiandrogen) was tested in a double-blind multicenter study involving 603 patients with advanced prostatic cancer. The estimated median survival time was significantly longer...
Journal Articles
Subject Area:
Further Areas
European Urology (1996) 29 (Suppl. 2): 34–36.
Published Online: 11 August 2017
... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Anandron™ Antiandrogens...
Journal Articles
Subject Area:
Further Areas
European Urology (1996) 29 (Suppl. 2): 37–39.
Published Online: 11 August 2017
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Anandron™ Antiandrogens Bicalutamide Casodex™ Combined androgen blockade Eulexin™ Flutamide Goserelin Nilutamide...
Journal Articles
Subject Area:
Further Areas
European Urology (1996) 29 (Suppl. 2): 83–95.
Published Online: 11 August 2017
...B.J.A Furr Casodex™ (bicalutamide, Zeneca Limited) was developed for the treatment of prostate cancer from a series of nonsteroidal compounds related to flutamide. Casodex is a selective antiandrogen that binds to rat, dog and human prostate androgen receptors, and has approximately a 4-fold higher...
Journal Articles
Subject Area:
Further Areas
European Urology (1991) 20 (Suppl. 1): 59–62.
Published Online: 11 August 2017
... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Antiandrogens Neuropharmacology Acute retention Uroflowmetry Benign...
Journal Articles
Subject Area:
Further Areas
European Urology (1988) 15 (3-4): 187–192.
Published Online: 11 August 2017
...C. Bouffioux The theoretical basis of ‘total androgen blockade’ in the treatment of advanced prostatic cancer is reviewed. The results of experimental and clinical data in the literature comparing medical or surgical castration alone versus castration plus peripheral antiandrogens are discussed...
Journal Articles
Subject Area:
Further Areas
European Urology (1996) 30 (4): 458–463.
Published Online: 11 August 2017
... Antiandrogens Abstract Objective: In a multicenter study, 905 patients with newly diagnosed advanced prostate cancer treated with flutamide were followed for safety and side effects. Methods: Flutamide was administered in monotherapy (75 patients (8 or as part of total androgen blockade (TAB groups): the latter...
Journal Articles
Subject Area:
Further Areas
European Urology (1996) 29 (Suppl. 2): 78–82.
Published Online: 11 August 2017
...C.W. Kuil; A.O. Brinkmann Information on the molecular structure of the human androgen receptor has increased insight into the molecular mechanism of action of androgens and antiandrogens. It has also facilitated the study of molecular defects in the androgen receptor gene associated with prostate...
Journal Articles
Subject Area:
Further Areas
European Urology (1979) 5 (5): 303–306.
Published Online: 11 August 2017
...U. Bracci Since prostatic carcinoma is hormone dependent, treatment of this tumor has been carried out in this department over the last 10 years employing antiandrogens, particularly cyproterone acetate(CPA), associated in some cases with orchiectomy. Of 500 patients thus treated, the author...
Journal Articles
Subject Area:
Further Areas
European Urology (1999) 36 (6): 549–558.
Published Online: 03 November 1999
... be offered to all patients. Currently, the LH-RH agonists are the drugs of choice for adjuvant therapy, whereas combined androgen blockade has generally been used as neoadjuvant therapy. Monotherapy with a nonsteroidal antiandrogen has considerable potential in both settings. Areas for future studies include...
Journal Articles
Subject Area:
Further Areas
European Urology (1999) 36 (Suppl. 2): 14–19.
Published Online: 11 October 1999
... was defined as PSA, local or systemic failure, has shown that the antiandrogen significantly improved the progression-free survival at 4 years (90 vs. 69%; p = 0.0029) [ 9 ]. However, when patients in whom the only indicator of progression was an increase in PSA are excluded, the proportion of men...
Journal Articles
Subject Area:
Further Areas
European Urology (1998) 34 (Suppl. 3): 12–17.
Published Online: 30 October 1998
...F.H. Schröder Castration or antiandrogen monotherapies remain options for prostate cancer treatment as only marginal benefits have been demonstrated with combined androgen blockade, although it may be that certain subgroups of patient may benefit. Of the nonsteroidal antiandrogens, bicalutamide 150...
Journal Articles